Results 221 to 230 of about 144,800 (349)

Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain. [PDF]

PLoS One
Zin CS, Lando S, González-Ortiz A, Mahalingasivam V, Mostafaei S, Ahmad WR, Ahmad Shah MM, Wettermark B, Carrero JJ.   +8 more
europepmc   +1 more source

Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: A matched cohort study [PDF]

Nicole Robertson, Anthony A. Mangino, Anna-Maria South, Laura Fanucchi   +3 more
openalex   +1 more source

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada

Addiction, EarlyView.
Abstract Background and aims Canada's drug toxicity crisis has been largely attributed to a volatile fentanyl‐dominated unregulated drug supply with increasing reports of fentanyl detected in combination with benzodiazepines, stimulants and xylazine.
Shaleesa Ledlie, Ria Garg, Pamela Leece, Gillian Kolla, Elaine Hyshka, Mina Tadrous, Tara Gomes   +6 more
wiley   +1 more source

Estimating the Need for Naloxone Distribution from United States Emergency Departments. [PDF]

J Am Coll Emerg Physicians Open
Mannerings AOK, Stader DE, Wilkerson RG, Neuenschwander J, Weiner SG.   +4 more
europepmc   +1 more source

Re: The association between glucose‐dependent insulinotropic polypeptide and/or glucagon‐like peptide‐1 receptor agonist prescriptions and substance‐related outcomes in patients with opioid and alcohol use disorders: A real‐world data analysis [PDF]

Yanning Wang, Almut G. Winterstein
openalex   +1 more source

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA

Addiction, EarlyView.
Abstract Background and aims The state of Kentucky has been heavily impacted by the ongoing opioid crisis in the United States, with high overdose mortality, high prevalence of opioid use disorder (OUD), elevated maternal mortality and incidence of Neonatal Abstinence Syndrome.
Hilary L. Surratt, Olivia A. Davis, Elizabeth O. Nelson, Hayley Durr, Karen Fawcett, Jason Joy, Brandon L. Schanbacher, Marie Vice, John A. Bauer, Wendy F. Hansen   +9 more
wiley   +1 more source

Call to Action: The Hidden Role of Anesthesiologists in the Opioid Epidemic. [PDF]

Anesth Analg
Boulos NM, Zhou A, Nguyen EK, Joosten A.
europepmc   +1 more source

Is Abstinence From Illicit Substances Related to PTSD Treatment Outcomes in Those With Co-Occurring PTSD and Opioid Use Disorder?

Jillian Giannini, Rebecca A. Cole, Peter Lontine, Kelly Peck   +3 more
openalex   +1 more source

Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder [PDF]

Theresa Winhusen, Frankie Kropp, Shelly F. Greenfield, Elizabeth E. Krans, Daniel Lewis, Peter Martin, Adam J. Gordon, Todd H. Davies, Elisha M. Wachman, Antoine Douaihy, Kea Parker, Xin Xie, Ali Jalali, Michelle R. Lofwall   +13 more
openalex   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, EarlyView.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source